We will be participating today at the AI Applications for Big Data in (Bio)Pharma. Our Sr Dir of Strategic Partnerships will be covering the topic of Data Contracting & Ownership Models at 12:35-1:05p ET.
Make sure to tune in!
#RNA#BigData
We will be participating in the upcoming AI Applications for Big Data in (Bio)Pharma taking place 5/19. Our Sr Dir of Strategic Partnerships will be covering the topic of Data Contracting & Ownership Models at 12:35-1:05p ET.
To register: bit.ly/3LeSJH3#RNA#BigData
Today is the Day Two of the 33rd Annual Cancer Progress Conference!
Make sure to listen in to the panel Does RNA Rule the World (2:30-3:30p ET) where Envisagenics' Co-founder & CEO will be participating.
More info: cancerprogress.live/#RNA#DrugDiscovery
Envisagenics’ Co-founder & CEO will be participating at the Cancer Progress Conference by Lumanity (5/10-12). Panel will take place on Day 2 of the virtual event and topic will cover Does RNA Rule the World?
More info: cancerprogress.live#RNA#Splicing#DrugDiscovery
Thank you to those who came by Envisagenics' poster session yesterday @AACR hosted by Alyssa Casill (@alyssacasill)! Great turnout discussing how Envisagenics' SpliceCore platform discovered novel RNA therapeutics for #breastcancer using AI/ML.
#RNA#Splicing#DrugDiscovery
It’s not often that we get to meet with our team members in-person, but we’re very glad that we were able to do so!
Here’s to Envisagenics’ team outing and the fantastic work we are doing in the AI/ML and RNA splicing sector of the industry. Cheers!
Excited to be participating at the American Association for Cancer Research in New Orleans, LA (April 8-13).
Our poster will be in Section 26 (Exhibit Halls D-H). Make sure to add to your agenda!
For more info: abstractsonline.com/pp8/#!/1…#RNA#Splicing#DrugDiscovery#AACR
Envisagenics' Co-founder & CTO, @makerman30, will be participating in a panel at @OGConferences Biologics UK with MiNA Therapeutics, Stoke Therapeutics, Regulus Therapeutics, and GSK.
Starts at 2:30pm GMT. Make sure to listen in!
#RNA#Splicing#DrugDiscovery
Thank you @CSHL for mentioning us on your podcast interview on the importance of #DEI !
Take a listen in to RK Narayanan (@RKNarayanan), who is the Sr. Dir. of Business Development and Technology Transfer at CSHL.
Link to podcast: podcasts.apple.com/us/podcas…#RNA#WomenInStem
For those in #SXSW, hope you are all enjoying the event!
Envisagenics will be participating in a panel starting at 10:00am through 11:00am CT - make sure to listen in if you are interested in a The $5T Opportunity: Gender Parity in Tech.
It is day two of @SMipharm's AI in Drug Discovery event!
The Use of AI in Drug Discovery for the Treatment of Rare Diseases will be starting at 14:40 GMT.
Make sure to listen in!
#RNA#ArtificialIntelligence#Splicing#DrugDiscovery
Envisagenics' Co-founder & CEO will be attending @SMipharm AI in Drug Discovery. Maria will be participating in a panel at 14:40GMT (The Use of AI in Drug Discovery for the Treatment of Rare Diseases).
Make sure to stop by our session!
#DrugDiscovery#ArtificialIntelligence
Envisagenics' Co-founder & CEO, Maria Luisa Pineda, PhD., will be participating at #SXSW alongside Priyanka Mitra (@M12vc), Michelle Zhu (@huuebio), and Cecilia Flores (@WebeeLife) to discuss gender parity across the industries. Panel will take place on March 15 10:00-11:00a CT.
News update from #AAIH! Here are the newly elected Board Leadership for 2022. Maria Luisa Pineda, our Co-founder & CEO, served as vice chair in 2021 and she looks forward to serving again in the Board Leadership as secretary.
Thank you to everyone who participated in the painting class! It was a joy to come together to share our creative spirits. The Envisagenics' team is gifted in so many ways. We look forward to the next happy hour event!
#RNA#Splicing#DrugDiscovery
International Day of Women & Girls in Science is a reminder for us that women and girls are essential to the opportunity and innovation in #STEM. As a women-led #biotech, today is like any other Friday – we tirelessly champion access to science for all women out there.